Literature DB >> 26718357

The Ki-67 labeling index and lymphatic/venous permeation predict the metastatic potential of rectal neuroendocrine tumors.

Shinya Sugimoto1, Kinichi Hotta2, Tadakazu Shimoda3, Kenichiro Imai1, Yuichiro Yamaguchi1, Takashi Nakajima3, Takuma Oishi3, Keita Mori4, Kohei Takizawa1, Naomi Kakushima1, Masaki Tanaka1, Noboru Kawata1, Hiroyuki Matsubayashi1, Hiroyuki Ono1.   

Abstract

BACKGROUND: Endoscopic resection has been used to treat small rectal neuroendocrine tumors (NETs). However, the indication for additional surgery after endoscopic resection is unclear. The aim of this study was to identify risk factors for rectal NET metastasis and to determine the indication for additional surgery.
METHODS: Fifty-five patients with a total of 57 rectal NETs, treated between October 2003 and January 2013, were retrospectively divided into metastatic (11 lesions) and non-metastatic (46 lesions) groups. Tumor size, central depression, invasion depth, lymphatic and venous permeation, mitotic activity, nuclear abnormality, Ki-67 labeling index, and World Health Organization grading classification (G1 or G2) were compared between the groups. Patients underwent endoscopic submucosal resection with a ligation device, transanal full-thickness surgical resection, or radical surgery.
RESULTS: By univariate analysis, the odds ratios (OR) for a Ki-67 labeling index >3.0 %, positive lymphatic or venous permeation, World Health Organization grading classification G2, tumor size >10 mm, submucosal invasion >4000 μm, and central depression were 120 (P < 0.001), 67.6 (P < 0.001), 58.7 (P < 0.001), 9.8 (P = 0.0037), 6.8 (P = 0.012), and 5.7 (P = 0.018), respectively. Multivariate logistic regression analyses showed that vascular permeation (OR 111; P = 0.006) and a Ki-67 labeling index >3.0 % (OR 88; P = 0.012) were independent risk factors for metastasis.
CONCLUSIONS: The Ki-67 labeling index and lymphatic/venous permeation were reliable predictors of rectal NET metastases.

Entities:  

Keywords:  Ki-67 labeling index; Lymphatic permeation; Metastasis; Predictor; Rectal NET; Venous permeation

Mesh:

Substances:

Year:  2015        PMID: 26718357     DOI: 10.1007/s00464-015-4735-3

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  28 in total

1.  Pathologic analysis of carcinoids. Histologic reevaluation of 62 cases.

Authors:  J Soga; K Tazawa
Journal:  Cancer       Date:  1971-10       Impact factor: 6.860

2.  Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups.

Authors:  Steven N Hochwald; Sui Zee; Kevin C Conlon; Roberto Colleoni; Otway Louie; Murray F Brennan; David S Klimstra
Journal:  J Clin Oncol       Date:  2002-06-01       Impact factor: 44.544

3.  Classification of low-grade neuroendocrine tumors of midgut and unknown origin.

Authors:  Susanne Van Eeden; Pascal F H J Quaedvlieg; Babs G Taal; G Johan A Offerhaus; Cornelis B H W Lamers; Marie-Louise F Van Velthuysen
Journal:  Hum Pathol       Date:  2002-11       Impact factor: 3.466

4.  Endoscopic submucosal resection of rectal carcinoid tumors with a ligation device.

Authors:  Akiko Ono; Takahiro Fujii; Yutaka Saito; Takahisa Matsuda; Daniel T y Lee; Takuji Gotoda; Daizo Saito
Journal:  Gastrointest Endosc       Date:  2003-04       Impact factor: 9.427

Review 5.  Review article: current status of gastrointestinal carcinoids.

Authors:  J M Läuffer; T Zhang; I M Modlin
Journal:  Aliment Pharmacol Ther       Date:  1999-03       Impact factor: 8.171

6.  An analysis of 8305 cases of carcinoid tumors.

Authors:  I M Modlin; A Sandor
Journal:  Cancer       Date:  1997-02-15       Impact factor: 6.860

7.  Carcinoid tumors of the rectum: effect of size, histopathology, and surgical treatment on metastasis free survival.

Authors:  A N Koura; G G Giacco; S A Curley; J M Skibber; B W Feig; L M Ellis
Journal:  Cancer       Date:  1997-04-01       Impact factor: 6.860

Review 8.  Carcinoids of the rectum: an evaluation of 1271 reported cases.

Authors:  J Soga
Journal:  Surg Today       Date:  1997       Impact factor: 2.540

Review 9.  One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

Authors:  James C Yao; Manal Hassan; Alexandria Phan; Cecile Dagohoy; Colleen Leary; Jeannette E Mares; Eddie K Abdalla; Jason B Fleming; Jean-Nicolas Vauthey; Asif Rashid; Douglas B Evans
Journal:  J Clin Oncol       Date:  2008-06-20       Impact factor: 44.544

10.  Clinicopathological characteristics and prognosis of rectal well-differentiated neuroendocrine tumors.

Authors:  Shunsuke Tsukamoto; Shin Fujita; Tomohiro Yamaguchi; Seiichiro Yamamoto; Takayuki Akasu; Yoshihiro Moriya; Hirokazu Taniguchi; Tadakazu Shimoda
Journal:  Int J Colorectal Dis       Date:  2008-07-02       Impact factor: 2.571

View more
  12 in total

Review 1.  Ki67 labeling index: assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Günter Klöppel; Stefano La Rosa
Journal:  Virchows Arch       Date:  2017-11-13       Impact factor: 4.064

2.  Predictive Factors for Lymph Node Metastasis and Prognostic Factors for Survival in Rectal Neuroendocrine Tumors.

Authors:  Beonghoon Sohn; Yoomin Kwon; Seung-Bum Ryoo; Inho Song; Yoon-Hye Kwon; Dong Woon Lee; Sang Hui Moon; Ji Won Park; Seung-Yong Jeong; Kyu Joo Park
Journal:  J Gastrointest Surg       Date:  2017-10-18       Impact factor: 3.452

Review 3.  Rectal neuroendocrine neoplasms: what the radiologists should know.

Authors:  Mayur Virarkar; Dheeraj R Gopireddy; Ajaykumar C Morani; Ahmad Alkhasawneh; Sergio Piotr Klimkowski; Sindhu Kumar; Chandana Lall; Priya Bhosale
Journal:  Abdom Radiol (NY)       Date:  2022-03-14

4.  A novel risk-scoring system for predicting lymph node metastasis of rectal neuroendocrine tumors.

Authors:  Keigo Chida; Jun Watanabe; Kingo Hirasawa; Yoshiaki Inayama; Toshihiro Misumi; Chikara Kunisaki; Itaru Endo
Journal:  Ann Gastroenterol Surg       Date:  2020-06-10

5.  Endoscopic submucosal resection with an endoscopic variceal ligation device for the treatment of rectal neuroendocrine tumors.

Authors:  Masahide Ebi; Shoko Nakagawa; Yoshiharu Yamaguchi; Yasuhiro Tamura; Shinya Izawa; Yasutaka Hijikata; Takaya Shimura; Yasushi Funaki; Naotaka Ogasawara; Makoto Sasaki; Takashi Joh; Kunio Kasugai
Journal:  Int J Colorectal Dis       Date:  2018-08-30       Impact factor: 2.571

Review 6.  Neuroendocrine neoplasms of the appendix, colon and rectum.

Authors:  Marco Volante; Federica Grillo; Federica Massa; Francesca Maletta; Luca Mastracci; Michela Campora; Jacopo Ferro; Alessandro Vanoli; Mauro Papotti
Journal:  Pathologica       Date:  2021-02

7.  Risk factors for lymph node metastasis and prognosis in colorectal neuroendocrine tumours.

Authors:  Xiuli Zheng; Mingli Wu; Limian Er; Huiyan Deng; Gongning Wang; Lingyao Jin; Shengmian Li
Journal:  Int J Colorectal Dis       Date:  2022-01-08       Impact factor: 2.571

8.  A 10-year History of a Diminutive Rectal Neuroendocrine Tumor.

Authors:  Katsuyuki Murai; Kenichiro Imai; Kinichi Hotta; Sayo Ito; Yuichiro Yamaguchi; Hiroyuki Ono
Journal:  Intern Med       Date:  2017-11-20       Impact factor: 1.271

9.  Clinicopathological heterogeneity between primary and metastatic sites of gastroenteropancreatic neuroendocrine neoplasm.

Authors:  Huiying Shi; Chen Jiang; Qin Zhang; Cuihua Qi; Hailing Yao; Rong Lin
Journal:  Diagn Pathol       Date:  2020-09-11       Impact factor: 2.644

Review 10.  MRI-detected extramural venous invasion of rectal cancer: Multimodality performance and implications at baseline imaging and after neoadjuvant therapy.

Authors:  Akitoshi Inoue; Shannon P Sheedy; Jay P Heiken; Payam Mohammadinejad; Rondell P Graham; Hee Eun Lee; Scott R Kelley; Stephanie L Hansel; David H Bruining; Jeff L Fidler; Joel G Fletcher
Journal:  Insights Imaging       Date:  2021-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.